NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Bruce Green, D.Ph

Practice Area Focus

  • Biologics
  • Drugs
  • Biosimilars
  • Combination Products
  • Rare Diseases
  • Generics
  • Pediatric Therapies
  • Clinical Pharmacology
  • Clinical Study Design
  • Modeling & Simulation
  • PKPD
  • Development Strategy
  • Post-marketing
  • Pediatric Trials

Biography

Bruce Green, D.Ph joined NDA Partners as an Expert Consultant in 2018. Dr. Green is an internationally recognized expert in the field of pharmacometrics, rare diseases, pediatric drug development, and dosing in obesity.

He was a former US Food and Drug Administration (FDA) Guest Reviewer in the Office of Clinical Pharmacology and Biopharmaceutics and a Tenured Senior Lecturer in the School of Pharmacy at the University of Queensland, Australia. He has held a Research Scientist position in the Center for Drug Development Science, University of California and was a Research Pharmacist at the Royal Brisbane Hospital, Australia.

Dr. Green has a keen interest in using modeling and simulation from pre-clinical through to post-marketing commitments. He maintains a research presence via his visiting Senior Lecturer position at the School of Pharmacy, King’s College London, London University and as an Adjunct Associate Professor in the School of Pharmacy at the University of Queensland, Australia.